# Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models

> **NCT07005414** · PHASE2 · COMPLETED · sponsor: **Fei Li** · enrollment: 66 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Bumetanide
- **BEHAVIORAL:** Treatment as usual (TAU)

## Key facts

- **NCT ID:** NCT07005414
- **Lead sponsor:** Fei Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-04
- **Primary completion:** 2026-04-21
- **Final completion:** 2026-04-22
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07005414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07005414, "Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07005414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*